跳至主要内容
临床试验/NCT05840757
NCT05840757已完成不适用

Non-Invasive MOnitoring in Transcathether Aortic Valve Implantation - A Single-center, Prospective, Interventional Study With the ClearSight® Finger Cuff

University of Basel2 个研究点 分布在 1 个国家目标入组 50 人开始时间: 2023年3月31日最近更新:
适应症

试验速览

阶段
不适用
状态
已完成
入组人数
50
试验地点
2
主要终点
Cardiac Output

研究概览

简要总结

In patients with severe aortic stenosis (AS) undergoing transcatheter aortic valve implantation (TAVI) minimal evidence is available for invasive hemodynamic monitoring and no evidence for tools able to measure traditionally invasive parameters non-invasively for peri-procedural guidance and post-interventional management.

The aim of this study is to evaluate the effectiveness and safety of a non-invasive hemodynamics monitoring tool called ClearSight for monitoring during TAVI procedures compared with standard invasive measurements.

详细描述

In patients with severe aortic stenosis (AS) undergoing transcatheter aortic valve implantation (TAVI) minimal evidence is available for invasive hemodynamic monitoring and no evidence for tools able to measure traditionally invasive parameters non-invasively for peri-procedural guidance and post-interventional management.

The aim of this study is to evaluate the effectiveness and safety of a non-invasive hemodynamics monitoring tool called ClearSight for monitoring during TAVI procedures compared with standard invasive measurements.

The ClearSight monitoring system works non-invasively by utilizing an inflatable finger cuff which adjusts automatically to measure the arterial blood pressure which enables the calculation of parameters such as cardiac output or index. Multiple studies have demonstrated the reliability and feasibility of continuous non-invasive monitoring, in different settings, however it was never performed in patients undergoing TAVI.

The ClearSight monitoring system will be directly compared to invasive measurements of hemodynamic parameters during the procedure. In addition, information regarding baseline hemodynamics and its changes during/after procedure may give important information on peri- and post-procedural management and short-term outcomes and discharge planning. A tool, providing this information non-invasively with the same accuracy might result in a major improvement in daily practice..

研究设计

研究类型
Interventional
分配方式
Na
干预模型
Single Group
主要目的
Diagnostic
盲法
None

入排标准

年龄范围
18 Years 至 —(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • Adult patients (>18 years old) with severe aortic stenosis undergoing elective TAVI.

排除标准

  • Emergency indication for TAVI
  • Severe tricuspid regurgitation
  • Severe mitral stenosis or severe regurgitation
  • Invasive right heart catheterization impossible
  • Dependency on right ventricle pacing immediately after TAVI implantation
  • Vulnerable subjects
  • Known or suspected non-compliance, drug or alcohol abuse
  • Participation in another investigation with an investigational drug or another MD within the 30 days preceding and during the present investigation affecting this study
  • Previous enrolment into the current investigation

结局指标

主要结局

Cardiac Output

时间窗: During aortic valve implantation which generally takes about 40mins

Cardiac Output (CO in L/min)

Diastolic blood pressure

时间窗: During aortic valve implantation which generally takes about 40mins

diastolic blood pressure (dBP in mmHg)

Cardiac Index

时间窗: During aortic valve implantation which generally takes about 40mins

Cardiac Index (CI in L/min/m2)

Systolic blood pressure

时间窗: During aortic valve implantation which generally takes about 40mins

systolic blood pressure (sBP in mmHg)

次要结局

未报告次要终点

研究者

申办方类型
Other
责任方
Principal Investigator
主要研究者

Thomas Nestelberger

Head of Structural Cardiology

University of Basel

研究点 (2)

Loading locations...

相似试验